Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-06-20 4:05 pm | N/A N/A | AGENUS INC | AGEN | Buell Jennifer Chairman Executive Council | 0 | $0 | 246,168 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-29 9:29 pm | N/A 2034-03-25 | Protagenic Therapeutics Inc. | PTIX | Buell Jennifer Director | 75,000 | $1.74 | 75,000 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 8:00 pm | N/A 2034-01-16 | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 1,160,919 | $0 | 1,160,919 (Direct) | View |
| 2023-10-11 Other | 2023-10-13 8:18 pm | N/A N/A | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 695,750 | $0 | 927,915 (Direct) | View |
| 2023-10-11 Option Award | 2023-10-13 8:18 pm | N/A N/A | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 695,750 | $0 | 927,915 (Direct) | View |
| 2023-09-29 Tax Withholding | 2023-10-03 9:15 pm | N/A N/A | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 25,000 | $1.1538 | 927,915 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-03 9:15 pm | N/A N/A | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 58,550 | $1.0445 | 927,915 (Direct) | View |
| 2023-10-03 Tax Withholding | 2023-10-03 9:15 pm | N/A N/A | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 65,000 | $0.9449 | 927,915 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 4:30 pm | N/A N/A | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 695,750 | $0 | 1,772,215 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:58 pm | N/A 2033-01-09 | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 500,000 | $0 | 880,715 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:58 pm | N/A N/A | MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer | 171,990 | $2.32 | 880,715 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 5:20 pm | N/A 2032-01-21 | MiNK Therapeutics Inc. | INKT | Buell Jennifer See Remarks | 679,800 | $0 | 679,800 (Direct) | View |
Ownership | 2021-10-20 6:53 pm | N/A N/A | MiNK Therapeutics Inc. | INKT | Buell Jennifer See Remarks | 0 | $0 | 1,808,950 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 7:34 pm | N/A N/A | AGENUS INC | AGEN | Buell Jennifer COO and President | 10,597 | $5.49 | 1,027,091 (Direct) | View |
| 2021-06-15 Option Award | 2021-07-02 7:34 pm | N/A 2030-12-17 | AGENUS INC | AGEN | Buell Jennifer COO and President | 900,000 | $0 | 1,027,091 (Direct) | View |
| 2021-04-02 Option Award | 2021-04-05 09:06 am | N/A N/A | AGENUS INC | AGEN | Buell Jennifer President & COO | 80,838 | $2.87 | 116,494 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 12:41 pm | N/A 2030-12-17 | AGENUS INC | AGEN | Buell Jennifer COO and President | 900,000 | $0 | 900,000 (Direct) | View |
| 2020-07-18 Option Award | 2020-07-21 5:06 pm | 2020-07-18 2030-07-18 | Protagenic Therapeutics Inc. | PTIX | Buell Jennifer Director | 145,000 | $1.75 | 145,000 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 4:01 pm | N/A 2030-06-15 | AGENUS INC | AGEN | Buell Jennifer COO and President | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-12-24 Option Award | 2019-12-27 12:58 pm | N/A 2029-12-24 | AGENUS INC | AGEN | Buell Jennifer Chief Operating Officer | 500,000 | $0 | 500,000 (Direct) | View |